Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Ranking and Category

  • 148th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Pharmaceutical Design, Volume 8 - Number 26



Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?

, 8(26): 2299 - 2332

Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borea, Katia Varani, Giorgia Pastorin, Tatiana Da Ros, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo and Giampiero Spalluto


DOI: 10.2174/1381612023392838





Structure-Activity Relationships of Suramin and Pyridoxal-5-phosphate Derivatives as P2 Receptor Antagonists

, 8(26): 2371 - 2399

Gunter Lambrecht, Kirsten Braun, Susanne Damer, Matthias Ganso, Caren Hildebrandt, Heiko Ullmann, Matthias U. Kassack and Peter Nickel


DOI: 10.2174/1381612023392973





Editor-in-Chief

William A. Banks
(29546 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA

Biography View Full Editorial Board

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

National Kidney MonthCoronaviruses-JOIN-EDITORIAL-BOARDNational Colorectal Cancer Awareness Month Multiple Myeloma Awareness MonthBrain Injury Awareness Month

Related Journals

Related eBooks

eBooks Catalog